Posts tagged ‘EORTC-NCI-AACR-Molecular Targets 2012’
August 6th, 2012
When the dog days of summer and the Olympics are over, the normal rhythm of pharma marketing and new product development life continues with the major medical congresses and scientific meetings that take place in the Autumn/Fall.
A few of the meetings we will be attending and ones to watch out for include:
ESMO 2012 Congress, Vienna (#ESMO12) 28 September – 2 October, 2012
Building on the highly successful European Multidisciplinary Cancer Congress held in Stockholm last year, we expect the 2012 Congress of the European Society of Medical Oncology (ESMO) to be an exciting meeting.
ESMO have already announced that abstract submissions are up 30%. We expect a lot of interesting new data to be presented in Vienna, especially in light of the fact that the deadline for presentation at ASCO in June was very early this year. If you are interested in attending, the late registration deadline is August 22nd.
NYAS Pancreatic Cancer: Translation of New Ideas, New York, 12 October, 2012
For those interested in pancreatic cancer and insights into some of the preclinical and translational research that is being done with targeted drugs, a half-day meeting at The New York Academy of Sciences (NYAS) looks worth attending.
The keynote speaker is Dafna Bar-Sagi, PhD, Professor and Vice Dean for Science at the NYU Langone Medical Center. Icarus Consultants is pleased to be a promotional partner for the event. The inexpensive registration fee for nonmembers is only $40, with a networking reception to follow.
EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Dublin 6 – 9 November, 2012
Hosted by the European Organization for Research and Treatment (EORTC), National Cancer Institute (NCI) and American Association for Cancer Research (AACR), this symposium is one of Sally Church’s favorite meetings of the year, with its focus on innovation in drug development, target selection and new products.
We hope to see you in Vienna, New York or Dublin!